RESULTS	Treatment with budesonide lowered median 3-bromotyrosine levels compared with treatment with placebo , terbutaline , and budesonide-terbutaline ( 0.24 vs 0.64 , 0.62 , and 0.43 3-bromotyosine/tyrosine [ mmol/mol ] ; P < .05 ) and lowered median 3,5-dibromotyrosine levels compared with placebo and terbutaline treatments ( 0.04 vs 0.11 and 0.07 3,5-dibromotyrosine / tyrosine [ mmol/mol ] , P < .05 ) .\